Moreover, there have been several publications exploring the longitudinal accumulation of tau in the AD continuum using tau‐PET,25, 26 to exclude the risk of T− at baseline change to T+ at the follow‐up visits thereby influencing the conclusions, we further selected the subjects keeping A + T− or A − T+ all the visits and still found the similar results. This evidence concerns the gene MAPT and Alzheimer disease.